Neurobiological Mechanisms Involved in MDMA Seeking Behavior And

Total Page:16

File Type:pdf, Size:1020Kb

Neurobiological Mechanisms Involved in MDMA Seeking Behavior And Neurobiological Mechanisms Involved in MDMA-Seeking Behaviour and Relapse M. Juliana Orejarena PhD thesis Barcelona, 2010 Neurobiological Mechanisms Involved in MDMA-Seeking Behaviour and Relapse Maria-Juliana Orejarena Serrano Memoria` presentada per optar al grau de Doctor en Biologia per la Universitat Pompeu Fabra. Aquesta Tesi Doctoral ha estat realitzada sota la direccio´ de la Dra. Patricia Robledo i del Dr. Rafael Maldonado al Departament de Ciencies` Experimentals i de la Salut de la Universitat Pompeu Fabra Barcelona, 2010 A mi mama y mis hermanas, A Karolos Contents Contents vii List of Figures ix Abstract xi Resumen xiii 1 Introduction3 1.1 Motivation and Reward ..................... 3 1.1.1 The Brain Reward Pathways .............. 4 1.1.2 Role of Dopamine in Reward.............. 6 1.1.2.1 The Hedonic Hypothesis........... 6 1.1.2.2 The Learning Hypothesis........... 7 1.2 Drug Addiction.......................... 10 1.2.1 Theories of Drug Addiction............... 13 1.2.1.1 The Opponent Process Theory . 13 1.2.1.2 The Allostasis Theory............. 14 1.2.1.3 The Incentive Sensitization Theory . 16 1.2.2 Neurocircuitry of Addiction............... 17 1.3 Animal Models of Addiction .................. 22 1.3.1 Intra-Cranial Self Stimulation ............. 22 1.3.2 Conditioned Place Preference ............. 23 1.3.3 Operant Intravenous Drug Self-administration . 24 1.3.3.1 Acquisition................... 26 1.3.3.2 Extinction.................... 28 1.3.3.3 Reinstatement to Drug Seeking Behaviour . 29 1.3.3.4 The Yoked Control-Operant Paradigm . 29 1.3.4 Complementary Biochemical and Genetic Methods Used in Our Studies ................... 31 1.3.4.1 Microarray................... 31 1.3.4.2 Microdialysis.................. 34 1.4 MDMA............................... 35 vii viii CONTENTS 1.4.1 History........................... 36 1.4.2 Pharmacodynamics.................... 37 1.4.3 Pharmacokinetics and Neurotoxicity.......... 38 1.4.4 Abuse and Addiction .................. 42 1.4.5 Use Pattern: Relevance of Acute and Chronic Toler- ance ............................ 43 1.4.6 Acute Pharmacological Effects in Humans . 46 1.4.7 Acute Pharmacological Effects in Animals . 47 1.5 Mechanisms Involved in MDMA Reinforcement and Relapse 49 1.5.1 Participation of the Dopaminergic System . 49 1.5.2 Participation of the Serotonergic System . 50 1.5.2.1 5-HT2A Receptors............... 51 1.5.2.2 5-HT2AR: Structure, Second Messenger Ac- tivation Pathway and Distribution in the Brain 51 1.5.2.3 5-HT2AR Modulation of Dopamine . 54 1.5.2.4 5-HT2AR and MDMA-Induced Reinforcement .......................... 55 1.6 Neuroadaptive Changes Following Active versus Passive Drug- Administration .......................... 57 1.6.0.5 Gene Expression Changes .......... 58 1.6.0.6 Changes in Dopamine ............ 60 1.6.0.7 Changes in Receptor Binding Sites . 62 2 Working Hypothesis 67 3 Objectives 69 4 Results 73 4.1 Article 1, Trigo et al 2009..................... 73 4.2 Article 2, Orejarena et al 2009 .................. 81 4.3 Article 3, Fernandez-Castillo` et al 2009 (submitted) . 92 4.4 Article 4, Orejarena et al 2010 (submitted) . 124 5 Discussion 165 5.1 Passive versus Active MDMA Administration . 165 5.2 Involvement of 5-HT2AR in MDMA-Induced Reinforcement 172 5.3 Involvement of 5-HT2AR in Relapse to MDMA-Seeking Be- haviour............................... 175 6 Conclusions 181 References 213 Acknowledgements 215 Appendices 217 A Supplementary Material for Article 3 219 B Supplementary Material for Article 4 241 C List of Abbreviations 249 Index 255 Glossary 255 List of Figures 1.1 Brain Reward Pathways..................... 5 1.2 Opponent-Process Theory.................... 14 1.3 Allostasis Theory......................... 15 1.4 The Spiralling Distress Cycle of Addiction........... 15 1.5 Neurocircuitry of Addiction................... 18 1.6 Conditioned Place Preference Paradigm............ 23 1.7 The Yoked Control-Operant Paradigm............. 30 1.8 Microarray Expression Analysis................. 32 1.9 Microdialysis ........................... 34 1.10 MDMA Structure and Steroisomers............... 35 1.11 Pathways of MDMA Metabolism in Rats and Humans. 39 1.12 5-HT2AR Second Messenger Activation Pathway . 52 1.13 CNS distribution of the 5-HT2AR................ 53 1.14 5-HT2AR Modulation of Dopamine............... 55 1.15 Gene Expression Changes in Active vs Passive Drug Admin- istration............................... 61 5.1 Heat Map: Active vs Passive MDMA Administration . 169 ix Abstract (+) 3,4-methylenedioxymethamphetamine (MDMA), commonly known as “ecstasy”, is currently a highly consumed drug with liability to produce ad- diction in some individuals. MDMA induces unique psychoactive effects that clearly distinguish it from hallucinogenic or psychostimulant drugs. MDMA mainly enhances the activity of both the serotonergic and the do- paminergic system in the mesolimbic brain reward pathways. However, the neurobiological mechanisms underlying its possible addictive prop- erties are still not fully understood. In the present work, we have con- tributed to this subject by establishing that the serotonin 5-HT2A receptor, in contrast to what has been observed for other drugs of abuse, is critical for MDMA-induced reinforcement. Moreover, the pharmacological block- ade of this receptor can prevent cue-induced relapse. This effect is pos- sibly mediated by its excitatory control over basal and MDMA-induced increase in midbrain dopamine, as supported by our microdialysis data. Furthermore, we have also shown that MDMA can act as an interocep- tive cue to induce relapse to cocaine-seeking behaviour. Additionally, we demonstrated differential changes at the level of the dopaminergic brain reward pathway and gene expression changes in different brain areas, fol- lowing self-administered MDMA in comparison to passive administration. These results underpin the impact of a learning component in the reward- ing/reinforcing properties of MDMA, and provide new evidence for the serotonergic involvement in MDMA-seeking behavior and relapse. xi xii Abstract Resumen (+) 3,4-metilendioximetanfetamina (MDMA), popularmente conocida como “´extasis”, es una droga susceptible de producir adiccin en algunos individuos. Actualmente es consumida principalmente por adolescentes y jovenes.´ Los particulares efectos psicoactivos inducidos por la MDMA, permiten distinguirlo de manera clara de otros psicoestimulantes o com- puestos alucinogenos.´ Esta droga actua´ principalmente activando el sis- tema dopaminergico´ y serotonergico´ en los circuitos neurales de placer. Sin embargo, los mecanismos neurobiologicos´ implicados en las propiedades adictivas de esta droga no han sido aun´ esclarecidos. El trabajo presentado en esta Tesis Doctoral ha puesto de manifiesto algunos aspectos claves de estos procesos que eran desconocidos hasta el momento. Hemos encontrado que el receptor de serotonina 5-HT 2A par- ticipa de forma cr´ıtica en las propiedades reforzantes de la MDMA, con- trario a lo observado en el caso de otros psicoestimulantes. Ademas,´ el blo- queo farmacologico´ de este receptor puede prevenir la reinstauracion´ de la busqueda´ de la MDMA, desencadenada por un est´ımulo o clave previa- mente asociado a su consumo. Estos efectos pueden ser debidos al bloqueo del control excitatorio que normalmente ejercen estos receptores sobre los niveles de dopamina en estructuras mesol´ımbicas, como ha sido revelado en nuestros estudios de microdialisis.´ Hemos demostrado tambien´ que la MDMA puede actuar como clave interoceptiva y desencadenar la reca´ıda a la busqueda´ y consumo de coca´ına. Adicionalmente, nuestros estudios han mostrado que tanto la activacion´ del sistema dopaminergico´ mesol´ımbico, como los cambios en la expresion´ genica´ en diferentes areas´ cerebrales que ocurren tras la administracion´ de la MDMA, dependen de si el sujeto par- ticipa de manera activa en el consumo de esta droga, o si por el contrario xiii xiv Resumen la recibe de forma pasiva. En conclusion,´ este trabajo resalta la importancia de los procesos de aprendizaje y memoria sobre las propiedades reforzantes/recompensantes de la MDMA. Ademas,´ nuestras investigaciones aportan nuevas eviden- cias en relacion´ a la participacion´ del sistema serotonergico´ en la busqueda´ y reca´ıda al consumo de esta droga. Resumen 1 2 Resumen CHAPTER 1 Introduction 1.1 Motivation and Reward Motivation is an internal response of an individual that is the sum re- sult of a variety of neurophysiological factors that initiate, sustain and di- rect behaviour. In its most primary form, it involves homeostatic processes related to hunger, thirst and temperature regulation. Homeostasis occurs thanks to coordinated and self-regulated processes, that allow an organ- ism to achieve a dynamic equilibrium and maintain stability while adjust- ing to changing conditions. The result of these homeostatic processes are instances of motivation, called drive states. Drive states are characterized by tension and discomfort due to a physiological need followed by relief when that need is satisfied. They are related to activities that enhance sur- vival or will ultimately support a given level of reproductive success such as eating, drinking and sexual behaviour. Thus, rewarding stimuli are now recognized as hedonic incentives, causing neural representations that elicit motivation and goal pursuit (Kandel, 2000). This, in turn, has resulted in the evolution of an oriented sequence of behaviours either toward specific 3 4 1. Introduction
Recommended publications
  • Epigenetic Regulation of the PTEN–AKT–RAC1 Axis by G9a Is Critical for Tumor Growth in Alveolar Rhabdomyosarcoma Akshay V
    Published OnlineFirst March 4, 2019; DOI: 10.1158/0008-5472.CAN-18-2676 Cancer Molecular Cell Biology Research Epigenetic Regulation of the PTEN–AKT–RAC1 Axis by G9a Is Critical for Tumor Growth in Alveolar Rhabdomyosarcoma Akshay V. Bhat1, Monica Palanichamy Kala1, Vinay Kumar Rao1, Luca Pignata2, Huey Jin Lim3, Sudha Suriyamurthy1, Kenneth T.Chang4,Victor K. Lee3, Ernesto Guccione2, and Reshma Taneja1 Abstract Alveolar rhabdomyosarcoma (ARMS) is an aggressive suppressor PTEN was a direct target gene of G9a. G9a pediatric cancer with poor prognosis. As transient and stable repressed PTEN expression in a methyltransferase activity– modifications to chromatin have emerged as critical dependent manner, resulting in increased AKT and RAC1 mechanisms in oncogenic signaling, efforts to target epige- activity. Re-expression of constitutively active RAC1 in G9a- netic modifiers as a therapeutic strategy have accelerated in deficient tumor cells restored oncogenic phenotypes, demon- recent years. To identify chromatin modifiers that sustain strating its critical functions downstream of G9a. Collectively, tumor growth, we performed an epigenetic screen and our study provides evidence for a G9a-dependent epigenetic found that inhibition of lysine methyltransferase G9a sig- program that regulates tumor growth and suggests targeting nificantly affected the viability of ARMS cell lines. Targeting G9a as a therapeutic strategy in ARMS. expression or activity of G9a reduced cellular proliferation and motility in vitro and tumor growth in vivo.Transcrip- Significance: These findings demonstrate that RAC1 is an tome and chromatin immunoprecipitation–sequencing effector of G9a oncogenic functions and highlight the poten- analysis provided mechanistic evidence that the tumor- tial of G9a inhibitors in the treatment of ARMS.
    [Show full text]
  • Addiction, Opioids, and Beyond
    Addiction, Opioids and Beyond Chronic Pain Mental Illness Substance Dep Medical Illness Genetics/Env Objectives Understanding Definitions in Substance Dependency and Addiction. Review of Basic Epidemiology in Opioids Understanding Basic Addiction Physiology and how it relates to Schizophrenia Knowledge the General Overview of SUD Treatment Knowledge of non-pharmacological treatments of SUD. Understanding of Prescription Opioids, Side Effects and Dangers Understanding Prescription Opioids in the setting of Chronic Pain Understand MAT for Opioids (Tip43) with Naltrexone, Methadone and Buprenorphine Naloxone WHAT DOES ADDICTION MEAN? In 2016 11.5 million people 12 years and older misused opioid pain medications 1.8 million had substance use disorder involving prescription pain medications Between 2000 to 2015, more then 500,000 person died from opioid overdoses Opioid and 2012 clinicians wrote 259 million prescription for opioids Overdose 2.5 million people with Opioid Addiction (JAMA) US deaths from drug overdoses hit record high in 2014, propelled by abuse of prescription painkillers and heroin. (CDC) Heroin related deaths tripled since 2010. Only 2.2% of US Physician have waiver to prescribe Buprenorphine (JAMA) Statistically, nonmedical use of drugs from individuals obtained a majority of their drugs from friends and relatives, however 80% of those “friends and family” obtained from ONE DOCTOR. Addiction Poorly Understood • Regard Addiction as a moral problem • Fail to adequately screen • 1% of medical school curriculum • Believe interventions are ineffective JAMA,2003,290, 1299 Defining the Word "Addiction" The American Society of Addiction Medicine (ASAM), American Pain Society (APS), and American Academy of Pain Medicine (AAPM) define addiction as a primary, chronic, neurobiological disease with genetic, psychosocial, and environmental factors influencing its development and manifestations characterized by one or more of the behaviors listed above (ASAM, 2001).
    [Show full text]
  • Overexpression of the Histone Dimethyltransferase G9a in Nucleus Accumbens Shell Increases Cocaine Self- Administration, Stress-Induced Reinstatement, and Anxiety
    The Journal of Neuroscience, January 24, 2018 • 38(4):803–813 • 803 Neurobiology of Disease Overexpression of the Histone Dimethyltransferase G9a in Nucleus Accumbens Shell Increases Cocaine Self- Administration, Stress-Induced Reinstatement, and Anxiety X Ethan M. Anderson,1 Erin B. Larson,1 XDaniel Guzman,1 Anne Marie Wissman,1 Rachael L. Neve,2 XEric J. Nestler,3 and X David W. Self1 1Department of Psychiatry, The Seay Center for Basic and Applied Research in Psychiatric Illness, University of Texas Southwestern Medical Center, Dallas, Texas, 75390, 2Viral Gene Transfer Core, Department of Brain and Cognitive Sciences, McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, and 3Icahn School of Medicine at Mount Sinai, Department of Neuroscience, New York, New York 10029 Repeated exposure to cocaine induces lasting epigenetic changes in neurons that promote the development and persistence of addiction. One epigenetic alteration involves reductions in levels of the histone dimethyltransferase G9a in nucleus accumbens (NAc) after chronic cocaine administration. This reduction in G9a may enhance cocaine reward because overexpressing G9a in the NAc decreases cocaine- conditioned place preference. Therefore, we hypothesized that HSV-mediated G9a overexpression in the NAc shell (NAcSh) would attenuate cocaine self-administration (SA) and cocaine-seeking behavior. Instead, we found that G9a overexpression, and the resulting increase in histone 3 lysine 9 dimethylation (H3K9me2), increases sensitivity to cocaine reinforcement and enhances motivation for cocaine in self-administering male rats. Moreover, when G9a overexpression is limited to the initial 15 d of cocaine SA training, it produces an enduring postexpression enhancement in cocaine SA and prolonged (over 5 weeks) increases in reinstatement of cocaine seeking induced by foot-shock stress, but in the absence of continued global elevations in H3K9me2.
    [Show full text]
  • Wnt Signaling in Vertebrate Neural Development and Function
    J Neuroimmune Pharmacol (2012) 7:774–787 DOI 10.1007/s11481-012-9404-x INVITED REVIEW Wnt Signaling in Vertebrate Neural Development and Function Kimberly A. Mulligan & Benjamin N. R. Cheyette Received: 18 June 2012 /Accepted: 10 September 2012 /Published online: 27 September 2012 # Springer Science+Business Media, LLC 2012 Abstract Members of the Wnt family of secreted signaling immature neurons migrate to populate different cortical proteins influence many aspects of neural development and layers, nuclei, and ganglia in the forebrain, midbrain, hind- function. Wnts are required from neural induction and axis brain, and spinal cord. Each mature neuron elaborates an formation to axon guidance and synapse development, and axon and numerous dendrites while forming hundreds to even help modulate synapse activity. Wnt proteins activate a thousands of synapses with other neurons, enabling electro- variety of downstream signaling pathways and can induce a chemical communication throughout the nervous system. similar variety of cellular responses, including gene tran- All these developmental processes must be coordinated to scription changes and cytoskeletal rearrangements. This re- ensure proper construction and function of the CNS, and view provides an introduction to Wnt signaling pathways this requires the coordinated developmental activity of a and discusses current research on their roles in vertebrate vast array of genes. neural development and function. Members of the Wnt family of secreted signaling proteins are implicated in every step of neural development men- Keywords Wnt signaling . Neural development . tioned above. Wnt proteins provide positional information CNS patterning . Axon guidance . Dendrite growth . within the embryo for anterior-posterior axis specification of Synapse formation .
    [Show full text]
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • Protein Domain-Level Landscape of Cancer-Type-Specific Somatic We Explored the Protein Domain-Level Landscape of Cancer-Type-Specific Somatic Mutations
    RESEARCH ARTICLE Protein Domain-Level Landscape of Cancer- Type-Specific Somatic Mutations Fan Yang1,2,3, Evangelia Petsalaki2,3, Thomas Rolland4,5, David E. Hill4, Marc Vidal4, Frederick P. Roth1,2,3,4,6,7* 1 Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada, 2 Donnelly Centre, University of Toronto, Toronto, Ontario, Canada, 3 Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, Toronto, Ontario, Canada, 4 Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, 5 Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America, 6 Canadian Institute for Advanced Research, Toronto, Ontario, Canada, 7 Department of Computer Science, University of Toronto, Toronto, Ontario, Canada * [email protected] Abstract OPEN ACCESS Identifying driver mutations and their functional consequences is critical to our understand- Citation: Yang F, Petsalaki E, Rolland T, Hill DE, ing of cancer. Towards this goal, and because domains are the functional units of a protein, Vidal M, Roth FP (2015) Protein Domain-Level Landscape of Cancer-Type-Specific Somatic we explored the protein domain-level landscape of cancer-type-specific somatic mutations. Mutations. PLoS Comput Biol 11(3): e1004147. Specifically, we systematically examined tumor genomes from 21 cancer types to identify doi:10.1371/journal.pcbi.1004147 domains with high mutational density in specific tissues, the positions of mutational hotspots Editor: Mona Singh, Princeton University, United within these domains, and the functional and structural context where possible. While hot- States of America spots corresponding to specific gain-of-function mutations are expected for oncoproteins, Received: August 22, 2014 we found that tumor suppressor proteins also exhibit strong biases toward being mutated in Accepted: January 22, 2015 particular domains.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Neuroplasticity in the Mesolimbic System Induced by Sexual Experience and Subsequent Reward Abstinence
    Western University Scholarship@Western Electronic Thesis and Dissertation Repository 6-21-2012 12:00 AM Neuroplasticity in the Mesolimbic System Induced by Sexual Experience and Subsequent Reward Abstinence Kyle Pitchers The University of Western Ontario Supervisor Lique M. Coolen The University of Western Ontario Graduate Program in Anatomy and Cell Biology A thesis submitted in partial fulfillment of the equirr ements for the degree in Doctor of Philosophy © Kyle Pitchers 2012 Follow this and additional works at: https://ir.lib.uwo.ca/etd Recommended Citation Pitchers, Kyle, "Neuroplasticity in the Mesolimbic System Induced by Sexual Experience and Subsequent Reward Abstinence" (2012). Electronic Thesis and Dissertation Repository. 592. https://ir.lib.uwo.ca/etd/592 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. NEUROPLASTICITY IN THE MESOLIMBIC SYSTEM INDUCED BY SEXUAL EXPERIENCE AND SUBSEQUENT REWARD ABSTINENCE (Spine Title: Sex, Drugs and Neuroplasticity) (Thesis Format: Integrated Article) By Kyle Kevin Pitchers Graduate Program in Anatomy and Cell Biology A thesis submitted in partial fulfillment of the requirements for degree of Doctor of Philosophy The School of Graduate and Postdoctoral Studies The University of Western Ontario London, Ontario, Canada © Kyle K. Pitchers, 2012 THE UNIVERSITY
    [Show full text]
  • The Effects of Alcohol and Nicotine Pretreatment During Adolescence on Adulthood Responsivity to Alcohol Antoniette M
    University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School 2007 The effects of alcohol and nicotine pretreatment during adolescence on adulthood responsivity to alcohol Antoniette M. Maldonado University of South Florida Follow this and additional works at: http://scholarcommons.usf.edu/etd Part of the American Studies Commons Scholar Commons Citation Maldonado, Antoniette M., "The effects of alcohol and nicotine pretreatment during adolescence on adulthood responsivity to alcohol" (2007). Graduate Theses and Dissertations. http://scholarcommons.usf.edu/etd/2272 This Thesis is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. The Effects of Alcohol and Nicotine Pretreatment During Adolescence on Adulthood Responsivity to Alcohol by Antoniette M. Maldonado A thesis submitted in partial fulfillment of the requirements for the degree of Masters of Arts Department of Psychology College of Arts and Sciences University of South Florida Major Professor: Cheryl L. Kirstein, Ph.D. Mark Goldman, Ph.D. Toru Shimizu, Ph.D. David J. Drobes, Ph.D. Date of Approval: 18 October, 2007 Keywords: addiction, adolescent, alcohol-nicotine interactions, conditioned place preference, novelty preference © Copyright 2007, Antoniette M. Maldonado Dedication To my mom, Sylvia Ann Valdez. Mom, you are my very best friend and I do not know what I would have done without all of the support you gave me through every single step of this journey. You make such a difference in my life and I cannot even begin to describe how grateful I am to have you still here with me.
    [Show full text]
  • Genome-Wide Association Study Identifies Novel Loci Associated with Circulating Phospho- and Sphingolipid Concentrations
    Genome-Wide Association Study Identifies Novel Loci Associated with Circulating Phospho- and Sphingolipid Concentrations Ays¸e Demirkan1., Cornelia M. van Duijn1,2,3., Peter Ugocsai4., Aaron Isaacs1,2.*, Peter P. Pramstaller5,6,7., Gerhard Liebisch4., James F. Wilson8.,A˚ sa Johansson9., Igor Rudan8,10,11., Yurii S. Aulchenko1, Anatoly V. Kirichenko12, A. Cecile J. W. Janssens13, Ritsert C. Jansen14, Carsten Gnewuch4, Francisco S. Domingues5, Cristian Pattaro5, Sarah H. Wild8, Inger Jonasson9,11, Ozren Polasek11, Irina V. Zorkoltseva12, Albert Hofman3,13, Lennart C. Karssen1, Maksim Struchalin1, James Floyd15, Wilmar Igl9, Zrinka Biloglav16, Linda Broer1, Arne Pfeufer5, Irene Pichler5, Susan Campbell8, Ghazal Zaboli9, Ivana Kolcic11, Fernando Rivadeneira3,13,17, Jennifer Huffman18, Nicholas D. Hastie18, Andre Uitterlinden3,13,17, Lude Franke19, Christopher S. Franklin15, Veronique Vitart8,18, DIAGRAM Consortium{, Christopher P. Nelson20, Michael Preuss21, CARDIoGRAM Consortium{, Joshua C. Bis22, Christopher J. O’Donnell23,24, Nora Franceschini25, CHARGE Consortium, Jacqueline C. M. Witteman3,13, Tatiana Axenovich12, Ben A. Oostra2,13,26", Thomas Meitinger27,28,29", Andrew A. Hicks5", Caroline Hayward18", Alan F. Wright18", Ulf Gyllensten9", Harry Campbell8", Gerd Schmitz4", on behalf of the EUROSPAN consortium 1 Genetic Epidemiology Unit, Departments of Epidemiology and Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands, 2 Centre for Medical Sytems Biology, Leiden, The Netherlands, 3 Netherlands Consortium
    [Show full text]
  • Glial Insulin Regulates Cooperative Or Antagonistic Golden Goal/Flamingo
    RESEARCH ARTICLE Glial insulin regulates cooperative or antagonistic Golden goal/Flamingo interactions during photoreceptor axon guidance Hiroki Takechi1, Satoko Hakeda-Suzuki1*, Yohei Nitta2,3, Yuichi Ishiwata1, Riku Iwanaga1, Makoto Sato4,5, Atsushi Sugie2,3, Takashi Suzuki1* 1Graduate School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan; 2Center for Transdisciplinary Research, Niigata University, Niigata, Japan; 3Brain Research Institute, Niigata University, Niigata, Japan; 4Mathematical Neuroscience Unit, Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Japan; 5Laboratory of Developmental Neurobiology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan Abstract Transmembrane protein Golden goal (Gogo) interacts with atypical cadherin Flamingo (Fmi) to direct R8 photoreceptor axons in the Drosophila visual system. However, the precise mechanisms underlying Gogo regulation during columnar- and layer-specific R8 axon targeting are unknown. Our studies demonstrated that the insulin secreted from surface and cortex glia switches the phosphorylation status of Gogo, thereby regulating its two distinct functions. Non- phosphorylated Gogo mediates the initial recognition of the glial protrusion in the center of the medulla column, whereas phosphorylated Gogo suppresses radial filopodia extension by counteracting Flamingo to maintain a one axon-to-one column ratio. Later, Gogo expression ceases during the midpupal stage, thus allowing R8 filopodia to extend vertically into the M3 layer. These *For correspondence: results demonstrate that the long- and short-range signaling between the glia and R8 axon growth [email protected] (SH-S); cones regulates growth cone dynamics in a stepwise manner, and thus shapes the entire [email protected] (TS) organization of the visual system. Competing interests: The authors declare that no competing interests exist.
    [Show full text]
  • Inaugural – Dissertation
    INAUGURAL – DISSERTATION zur Erlangung der Doktorwürde der Naturwissenschaftlich-Mathematischen Gesamtfakultät der Ruprecht - Karls - Universität Heidelberg vorgelegt von Diplom-Biochemikerin Nadine Stephanie Kirsch geboren in Heidelberg Tag der mündlichen Prüfung: ……………………………………………. Analysis of novel Wnt pathway components acting at the receptor level Gutachter: Prof. Dr. Christof Niehrs Prof. Dr. Thomas Holstein Table of Contents Table of Contents 1. Summary .......................................................................................................................... 1 2. Zusammenfassung ........................................................................................................... 2 3. Introduction ..................................................................................................................... 3 3.1 Wnt signaling transduction cascades ......................................................................... 3 3.1.1 Wnt/β-catenin signaling ...................................................................................... 4 3.1.2 Wnt/PCP signaling ............................................................................................... 6 3.2 Wnt/β-catenin signaling regulation at the receptor level ......................................... 8 3.2.1 Wnt receptors ...................................................................................................... 8 3.2.2 Extracellular modifiers ......................................................................................
    [Show full text]